Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease - Results From EMPA-REG OUTCOME®. (Q40406675)
Jump to navigation
Jump to search
scientific article published on 23 December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease - Results From EMPA-REG OUTCOME®. |
scientific article published on 23 December 2016 |
Statements
1 reference
Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease - Results From EMPA-REG OUTCOME®. (English)
1 reference
Kohei Kaku
1 reference
Jisoo Lee
1 reference
Michaela Mattheus
1 reference
Stefan Kaspers
1 reference
Jyothis George
1 reference
Hans-Juergen Woerle
1 reference
EMPA-REG OUTCOME® Investigators
1 reference
23 December 2016
1 reference
1 reference
Identifiers
1 reference